It was found that the nanoparticle with high biosafety and high transfection efficiency was successfully constructed, which could effectively increase the expression of VS-1 in aortic aneurysms, while reducing the expression of hs-CRP, ICAM-1, VCAM-1, and TNF-a. This evidence concerns the gene VCAM1 and aortic aneurysm.